TAM
AMED

Telluride Asset Management’s Amedisys AMED Stock Holding History

Telluride Asset Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		$409K Buy
+24,456
New +$347K 0.35% 104

Other funds holding AMED

KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JCG
JHL Capital Group Chicago, Illinois $805M AUM 50.84% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Telluride Asset Management's AMED Position: Q2 2014 in Review

Telluride Asset Management opened a new position in Amedisys (AMED) in Q2 2014: 24,456 shares worth $409K. The stake represents 0.35% of the portfolio and ranks #104 among its holdings.

124 funds tracked by Wall St. Rank hold AMED as of Q2 2014.

  • Telluride Asset Management held 24,456 shares of Amedisys worth $409K as of Q2 2014.
  • Amedisys was a new Telluride Asset Management position in Q2 2014.
  • Amedisys made up 0.35% of Telluride Asset Management's portfolio in Q2 2014, its #104 holding.
  • 124 funds tracked by Wall St. Rank held Amedisys as of Q2 2014.

Based on Telluride Asset Management's 13F filing for Q2 2014, filed 14 Aug 2014.